Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies.

Katsumata K, Ishihara J, Mansurov A, Ishihara A, Raczy MM, Yuba E, Hubbell JA.

Sci Adv. 2019 Nov 6;5(11):eaay1971. doi: 10.1126/sciadv.aay1971. eCollection 2019 Nov.

2.

Engineering anti-cancer nanovaccine based on antigen cross-presentation.

Warrier VU, Makandar AI, Garg M, Sethi G, Kant R, Pal JK, Yuba E, Gupta RK.

Biosci Rep. 2019 Oct 30;39(10). pii: BSR20193220. doi: 10.1042/BSR20193220.

3.

Chondroitin Sulfate-Based pH-Sensitive Polymer-Modified Liposomes for Intracellular Antigen Delivery and Induction of Cancer Immunity.

Okubo M, Miyazaki M, Yuba E, Harada A.

Bioconjug Chem. 2019 May 15;30(5):1518-1529. doi: 10.1021/acs.bioconjchem.9b00221. Epub 2019 Apr 11.

PMID:
30945847
4.

Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia.

Kaviarasi S, Yuba E, Harada A, Krishnan UM.

J Control Release. 2019 Apr 28;300:22-45. doi: 10.1016/j.jconrel.2019.02.031. Epub 2019 Feb 22. Review.

PMID:
30802476
5.

Sonodynamic Therapeutic Effects of Sonosensitizers with Different Intracellular Distribution Delivered by Hollow Nanocapsules Exhibiting Cytosol Specific Release.

Teranishi R, Matsuda T, Yuba E, Kono K, Harada A.

Macromol Biosci. 2019 Apr;19(4):e1800365. doi: 10.1002/mabi.201800365. Epub 2019 Feb 1.

PMID:
30707494
6.

Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro.

Tsuruta M, Ueda S, Yew PY, Fukuda I, Yoshimura S, Kishi H, Hamana H, Hirayama M, Yatsuda J, Irie A, Senju S, Yuba E, Kamba T, Eto M, Nakayama H, Nishimura Y.

Oncoimmunology. 2018 Jan 5;7(4):e1415687. doi: 10.1080/2162402X.2017.1415687. eCollection 2018.

7.

Bleomycin-Loaded pH-Sensitive Polymer⁻Lipid-Incorporated Liposomes for Cancer Chemotherapy.

Yuba E, Osaki T, Ono M, Park S, Harada A, Yamashita M, Azuma K, Tsuka T, Ito N, Imagawa T, Okamoto Y.

Polymers (Basel). 2018 Jan 15;10(1). pii: E74. doi: 10.3390/polym10010074.

8.

Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.

Okazaki S, Iwasaki T, Yuba E, Watarai S.

J Vet Med Sci. 2018 Feb 9;80(2):197-204. doi: 10.1292/jvms.17-0491. Epub 2017 Dec 28.

9.

Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.

Miyazaki M, Yuba E, Hayashi H, Harada A, Kono K.

Bioconjug Chem. 2018 Jan 17;29(1):44-55. doi: 10.1021/acs.bioconjchem.7b00551. Epub 2017 Dec 12.

PMID:
29183110
10.

Liposome-based immunity-inducing systems for cancer immunotherapy.

Yuba E.

Mol Immunol. 2018 Jun;98:8-12. doi: 10.1016/j.molimm.2017.11.001. Epub 2017 Nov 8. Review.

PMID:
29128232
11.

pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity.

Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K.

Vaccines (Basel). 2017 Nov 4;5(4). pii: E41. doi: 10.3390/vaccines5040041.

12.

Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination.

Uchida S, Yoshinaga N, Yanagihara K, Yuba E, Kataoka K, Itaka K.

Biomaterials. 2018 Jan;150:162-170. doi: 10.1016/j.biomaterials.2017.09.033. Epub 2017 Sep 27.

PMID:
29031816
13.

In Vitro Sonodynamic Therapeutic Effect of Polyion Complex Micelles Incorporating Titanium Dioxide Nanoparticles.

Yamamoto S, Ono M, Yuba E, Harada A.

Nanomaterials (Basel). 2017 Sep 11;7(9). pii: E268. doi: 10.3390/nano7090268.

14.

Carboxylated phytosterol derivative-introduced liposomes for skin environment-responsive transdermal drug delivery system.

Yamazaki N, Yamakawa S, Sugimoto T, Yoshizaki Y, Teranishi R, Hayashi T, Kotaka A, Shinde C, Kumei T, Sumida Y, Shimizu T, Ohashi Y, Yuba E, Harada A, Kono K.

J Liposome Res. 2018 Dec;28(4):275-284. doi: 10.1080/08982104.2017.1369995. Epub 2017 Sep 5.

PMID:
28826275
15.

Development of pH-sensitive Dextran Derivatives with Strong Adjuvant Function and Their Application to Antigen Delivery.

Yuba E, Uesugi S, Miyazaki M, Kado Y, Harada A, Kono K.

Membranes (Basel). 2017 Aug 4;7(3). pii: E41. doi: 10.3390/membranes7030041.

16.

pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.

Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A, Kono K.

Biomaterials. 2017 Oct;141:272-283. doi: 10.1016/j.biomaterials.2017.07.001. Epub 2017 Jul 3.

PMID:
28704679
17.

Evaluation of a combination tumor treatment using thermo-triggered liposomal drug delivery and carbon ion irradiation.

Kokuryo D, Aoki I, Yuba E, Kono K, Aoshima S, Kershaw J, Saga T.

Transl Res. 2017 Jul;185:24-33. doi: 10.1016/j.trsl.2017.04.001. Epub 2017 Apr 21.

18.

Preparation of dual-stimuli-responsive liposomes using methacrylate-based copolymers with pH and temperature sensitivities for precisely controlled release.

Sugimoto T, Yamazaki N, Hayashi T, Yuba E, Harada A, Kotaka A, Shinde C, Kumei T, Sumida Y, Fukushima M, Munekata Y, Maruyama K, Kono K.

Colloids Surf B Biointerfaces. 2017 Jul 1;155:449-458. doi: 10.1016/j.colsurfb.2017.04.043. Epub 2017 Apr 23.

PMID:
28463812
19.

Effect of the side chain spacer structure on the pH-responsive properties of polycarboxylates.

Harada A, Teranishi R, Yuba E, Kono K.

J Biomater Sci Polym Ed. 2017 Jul - Aug;28(10-12):1025-1035. doi: 10.1080/09205063.2017.1324551. Epub 2017 May 5.

PMID:
28443362
20.

Doxorubicin Delivery Using pH and Redox Dual-Responsive Hollow Nanocapsules with a Cationic Electrostatic Barrier.

Teranishi R, Matsuki R, Yuba E, Harada A, Kono K.

Pharmaceutics. 2016 Dec 30;9(1). pii: E4. doi: 10.3390/pharmaceutics9010004.

Supplemental Content

Loading ...
Support Center